11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review


 

ADCs in HER2+ MBC: Durable Antitumor Activity of T-DXd in a Pretreated Patient Population

183 views
February 23, 2021
Comments 0
Login to view comments. Click here to Login